Implications for pelvic lymph node irradiation in definitive chemoradiotherapy of node negative muscle invasive bladder cancer based on predictive factors of clinicopathologic discrepancy
- 28 June 2022
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (6) , 2537-2542
Abstract
Purpose To identify pre-surgical imaging predictive value and factors associated with the clinicopathologic discrepancy for implication of definitive pelvic radiotherapy in clinically node-negative bladder cancer. Method The documented data of bladder cancer patients who underwent radical cystectomy plus pelvic lymphadenectomy were collected retrospectively. Patients’ characteristics, last imaging, pathology reports, disease-specific survival and overall survival were retrieved. Results From 142 patients, pre-surgical imaging had a sensitivity of 76.4%, specificity of 73.7%, positive predictive value (PPV) of 94.9%, and negative predictive value (NPV) of 32.6% (p value < 0.0001) for detection of muscle invasion. Also, for detection of positive lymph nodes, imaging had a sensitivity of 31.8%, specificity of 85.7%, PPV of 50%, and NPV of 73.7% (p value: 0.022). 44.4% of study population were upstaged after surgery (24.6% associated with N-upstaging) and 18.3% were downstaged (12% associated with N-downstaging). Receipt of neoadjuvant chemotherapy and T-stage were not correlated with N-upstaging. On multivariate analysis, lymphovascular invasion (LVI) maintained its significance for independent prediction of upstaging (OR 3.3, 95% CI 1.5–7.5, p value: 0.004) and inversely with downstaging (OR 0.34, 95% CI 0.12–0.96, p value: 0.04). Older age (OR 1.03, 95% CI 1.0–1.05, p value 0.047), positive margins (OR 2.1, 95% CI 1.2–3.8, p value 0.011), presence of LVI (OR 2.5, 95% CI 1.4–4.7, p value 0.003), perineural invasion (OR 2.0, 95% CI 1.2–3.4, p value 0.013), and lymph node ratio (OR 1.011, 95% CI 1.001–1.021, p value 0.03) were associated with worse survival. Also, N-upstaging independently predicted a worse survival after controlling for surgical pathology stage (OR 2.3, 95% CI 1.2–4.5, p value 0.011). Conclusions The optimal target volume in definitive chemoradiotherapy of node-negative bladder cancer patients remains to be established. Since then, customizing the treatment is considered especially for positive LVI in TURBT specimen.Keywords
This publication has 18 references indexed in Scilit:
- Clinical–Pathologic Stage Discrepancy in Bladder Cancer Patients Treated With Radical Cystectomy: Results From the National Cancer Data BaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Occult Pelvic Lymph Node Involvement in Bladder Cancer: Implications for Definitive RadiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2014
- Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Whole-Pelvis or Bladder-Only Chemoradiation for Lymph Node–Negative Invasive Bladder Cancer: Single-Institution ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcomeBJU International, 2012
- Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimensBJU International, 2010
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinomaBJU International, 2005
- Standardization of Radical Cystectomy and Pelvic Lymph Node Dissection for Bladder Cancer: A Collaborative Group ReportJournal of Urology, 2004
- Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomyUrology, 2003